New inhaler shows promise for COPD patients
NCT ID NCT07108699
First seen Apr 12, 2026 · Last updated May 15, 2026 · Updated 3 times
Summary
This study tests a new dry powder inhaler called HSK39004 in 180 adults aged 40 to 80 with COPD. The goal is to see if it improves lung function over 4 weeks compared to a placebo. Participants are randomly assigned to receive either the drug or an inactive inhaler, and neither they nor the doctors know which they get.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
West China Hospital of Sichuan University
Chengdu, Sichuan, China
Conditions
Explore the condition pages connected to this study.